Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort.

Xia Y, Seaman S, Hickman M, Macleod J, Robertson R, Copeland L, McKenzie J, De Angelis D.

Drug Alcohol Depend. 2015 Jun 1;151:76-83. doi: 10.1016/j.drugalcdep.2015.03.005. Epub 2015 Mar 18.

2.

Dihydrocodeine/Agonists for alcohol dependents.

Ulmer A, Müller M, Frietsch B.

Front Psychiatry. 2012 Mar 23;3:21. doi: 10.3389/fpsyt.2012.00021. eCollection 2012.

3.

Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.

Zamparutti G, Schifano F, Corkery JM, Oyefeso A, Ghodse AH.

Br J Clin Pharmacol. 2011 Aug;72(2):330-7. doi: 10.1111/j.1365-2125.2011.03908.x.

4.

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.

Cornish R, Macleod J, Strang J, Vickerman P, Hickman M.

BMJ. 2010 Oct 26;341:c5475. doi: 10.1136/bmj.c5475.

5.

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.

Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, Robertson JR.

BMJ. 2010 Jul 1;341:c3172. doi: 10.1136/bmj.c3172.

6.

The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification.

Sheard L, Wright NM, El-Sayeh HG, Adams CE, Li R, Tompkins CN.

Subst Abuse Treat Prev Policy. 2009 Feb 5;4:1. doi: 10.1186/1747-597X-4-1.

Supplemental Content

Support Center